2026 NPPES data Pulmonary Disease Physician NPI 1861402232 M.D.
Verify on CMS →

Barbara Schultz, M.D.

Pulmonary Disease Physician in New York, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,323 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 362 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
40%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Barbara Schultz, M.D. filed 2,293 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in New York, New York, prescribing 40% generic.

2K
Part D claims, 2023
40%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Barbara Schultz, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

2,293 Top 15% higher than 85% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2K+: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Barbara Schultz, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Barbara Schultz, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/09/2006

NPI 1861402232

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,323 US NPIs in this specialty

Medicare Part D claims

2,293 57% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in New York

How Pulmonary Disease Physician compares to other specialties among New York providers

New York providers
Student in an Organized Health Care Education/Training Program - 7.8%Student in an Organized Health Care Education/Training Program7.8%Registered Nurse - 5.2%Registered Nurse5.2%Clinical Social Worker - 4.9%Clinical Social Worker4.9%Social Worker - 4.5%Social Worker4.5%Speech-Language Pathologist - 4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse - 4.3%Licensed Practical Nurse4.3%Pulmonary Disease Physician - 0.1%Pulmonary Disease Physician0.1%
Largest specialties in New York (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Barbara Schultz, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 10 E 102ND ST, New York, NY, 10029, with a listed phone of (212) 241-5656. NPI 1861402232 was issued on 08/09/2006.

Medicare Part D records for calendar year 2023 show 2,293 prescription claims written by this provider, covering 362 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 59% brand-name and 40% generic by claim count.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,323 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

10 E 102ND ST
New York, NY 10029

Provider Details

NPI 1861402232
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Female
NPI Issued 08/09/2006

Hospital and facility affiliations

Facilities where Barbara Schultz, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Icahn School OF Medicine AT Mount Sinai
New York, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Barbara Schultz, M.D.. To verify Barbara Schultz, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Barbara Schultz, M.D. - brand share 59.0%
Pulmonary Disease Physician average

59% brand-name claims vs 40% generic, on 2,293 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,293
Total Claims
$1.1M
Total Drug Cost
362
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,418
Total Day Supply
97,249
Brand vs Generic
59% brand / 40% generic
Brand Drug Cost
$972K
Generic Drug Cost
$87K
Antibiotic Claims
113

Patient Demographics

Average Patient Age
77.3 years
Avg HCC Risk Score
1.73
Gender Split
67% female / 33% male
Age Distribution
<65: 17, 65-74: 121, 75-84: 150, 85+: 74

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Barbara Schultz, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
340
Breo Ellipta
Fluticasone/Vilanterol
139
Montelukast Sodium
129
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
126
Advair Hfa
Fluticasone Propion/Salmeterol
103
Symbicort
Budesonide/Formoterol Fumarate
94
Prednisone
91
Incruse Ellipta
Umeclidinium Bromide
90
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
80
Fluticasone Propionate
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How Barbara Schultz, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,323
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

Barbara Schultz, M.D.'s 2,293 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Schultz.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Barbara Schultz, M.D.'s specialty?
Barbara Schultz, M.D. specializes in Pulmonary Disease Physician and practices in New York, New York. Credentials: M.D..
How much does Barbara Schultz, M.D. prescribe under Medicare Part D?
In 2023, Barbara Schultz, M.D. wrote 2,293 Medicare Part D claims totaling $1.1M in drug costs for 362 beneficiaries.
Where is Barbara Schultz, M.D. located?
Barbara Schultz, M.D. is located at 10 E 102ND ST, New York, NY, 10029. Phone: (212) 241-5656.
What is Barbara Schultz, M.D.'s NPI number?
Barbara Schultz, M.D.'s National Provider Identifier (NPI) is 1861402232, issued on 08/09/2006.
Does Barbara Schultz, M.D. prescribe more brand-name or generic drugs?
Barbara Schultz, M.D.'s prescribing is 59% brand-name and 40% generic drugs by claim count, with $972K in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,323 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Barbara Schultz, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Barbara Schultz, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Breo Ellipta, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Barbara Schultz, M.D. accept Medicare?
Barbara Schultz, M.D. appears in CMS Medicare data with 2,293 Part D claims and 362 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Barbara Schultz, M.D.'s credentials?
Barbara Schultz, M.D.'s NPI is 1861402232 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.